Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy

AD Den Haan, BY Tan, MN Zikusoka… - Circulation …, 2009 - Am Heart Assoc
AD Den Haan, BY Tan, MN Zikusoka, LI Lladó, R Jain, A Daly, C Tichnell, C James
Circulation: Cardiovascular Genetics, 2009Am Heart Assoc
Background—Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an
inherited disorder typically caused by mutations in components of the cardiac desmosome.
The prevalence and significance of desmosome mutations among patients with ARVD/C in
North America have not been described previously. We report comprehensive desmosome
genetic analysis for 100 North Americans with clinically confirmed or suspected ARVD/C.
Methods and Results—In 82 individuals with ARVD/C and 18 people with suspected …
Background— Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited disorder typically caused by mutations in components of the cardiac desmosome. The prevalence and significance of desmosome mutations among patients with ARVD/C in North America have not been described previously. We report comprehensive desmosome genetic analysis for 100 North Americans with clinically confirmed or suspected ARVD/C.
Methods and Results— In 82 individuals with ARVD/C and 18 people with suspected ARVD/C, DNA sequence analysis was performed on PKP2, DSG2, DSP, DSC2, and JUP. In those with ARVD/C, 52% harbored a desmosome mutation. A majority of these mutations occurred in PKP2. Notably, 3 of the individuals studied have a mutation in more than 1 gene. Patients with a desmosome mutation were more likely to have experienced ventricular tachycardia (73% versus 44%), and they presented at a younger age (33 versus 41 years) compared with those without a desmosome mutation. Men with ARVD/C were more likely than women to carry a desmosome mutation (63% versus 38%). A mutation was identified in 5 of 18 patients (28%) with suspected ARVD. In this smaller subgroup, there were no significant phenotypic differences identified between individuals with a desmosome mutation compared with those without a mutation.
Conclusions— Our study shows that in 52% of North Americans with ARVD/C a mutation in one of the cardiac desmosome genes can be identified. Compared with those without a desmosome gene mutation, individuals with a desmosome gene mutation had earlier-onset ARVD/C and were more likely to have ventricular tachycardia.
Am Heart Assoc